6Rosenstock J, Schwartz SL, Clark CM Jr, et al, Basa linsulin therapy in type 2 Diabetes: 28 - week comparison of insulin glargine ( HOM901 ) and NPH insulin. Diabetes Care 2001 ;24:631 -636.
7HU S, WANG S, FANELLI B, et al. Pancreatic beta- cellK (ATP) channel activity and membrane - binding studies with nateglinide : a comparison with sulfonylureas and repaglinide [ j ]. j Pharmacol Exp Ther 2000;293(2) :444 -452
8MR Rizzo, M Barbieri, R Grella, N Passariello, M Barone, G Paolisso Diabetes Metab 2004;30:81 -89.
9Wenying Yang, Qiuhe Ji, Dalong Zhu, et al. Biphasie insulin aspart 30 three times daily is more effective than a twicedaily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs[J]. Diabetes Care, 2008,31(5) : 852-856.
10Hu S,Wang S,Fanell B,et al.Pancreatic beta-cell K(ATP) channel activity and membrane 2 binding studies with nateglinide:A comparison with sulfonylureas and repaglinide.J Pharmacol EXP Ther,2000,293:444-452
